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Abstract
Deep sequencing of transcriptome (RNA-seq) provides unprecedented opportunity to interrogate plausible mRNA splicing
patterns by mapping RNA-seq reads to exon junctions (thereafter junction reads). In most previous studies, exon junctions
were detected by using the quantitative information of junction reads. The quantitative criterion (e.g. minimum of two
junction reads), although is straightforward and widely used, usually results in high false positive and false negative rates,
owning to the complexity of transcriptome. Here, we introduced a new metric, namely Minimal Match on Either Side of
exon junction (MMES), to measure the quality of each junction read, and subsequently implemented an empirical statistical
model to detect exon junctions. When applied to a large dataset (.200M reads) consisting of mouse brain, liver and muscle
mRNA sequences, and using independent transcripts databases as positive control, our method was proved to be
considerably more accurate than previous ones, especially for detecting junctions originated from low-abundance
transcripts. Our results were also confirmed by real time RT-PCR assay. The MMES metric can be used either in this empirical
statistical model or in other more sophisticated classifiers, such as logistic regression.
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Introduction
Alternative splicing (AS), which invalidates the old theory of
‘‘one gene one protein’’, enables higher eukaryote to produce large
number of transcripts with limited number of genes, and has been
proposed as a primary driver of the evolution of phenotypic
complexity in mammals [1]. In human, ,95% of multi-exon
genes undergo alternative splicing, which explains the numerical
disparity between the low number of human protein-coding genes
(,26,000) and the high number of human proteins (more than
90,000) [2,3]. Alternative pre-messenger RNA splicing also
influences development, physiology, and disease; many studies
have reported the existence of cancer-specific alternative splicing
in the absence of genomic mutations (for a review see [4]).
Several methods have been applied to detect AS events.
Expression Sequence Tag (EST) was the first widely used
technology and played a leading role in detecting AS events.
However, except for the relatively high cost, EST technology has
many other limitations including genomic contamination, cloning
bias, paralog confusing, 39 gene bias and low sensitivity in
detecting low abundance transcripts. Besides, it also requires great
efforts for data interpretation [5]. Microarray technologies have
also played a prominent role in shaping our understanding of the
complexity of transcriptome [1,6,7]. Recently, whole-transcript
microarrays were used to monitor 24,426 alternative splicing
events in 48 human tissues and cell lines [8]. Although this
technology has been used extensively, limitations still persist;
including limited probe coverage, cross-hybridization artifacts,
requirement of previously known gene structures and difficulties in
data analysis, etc.
More recently, rapid progress in the development of massively
parallel sequencing such as Illumina/Solexa or Applied Biosys-
tems/SOLiD, has provided people unprecedented opportunities to
interrogate plausible alternative RNA splicing. Using these
technologies, tens of millions of short tags (25–75 bases) can now
be simultaneously sequenced at less than 1% the cost of traditional
Sanger methods. Deep sequencing of transcriptome (RNA-seq)
quickly becomes the most powerful technique to interrogate the
whole transcriptional landscape [9], including both known
transcript quantification and novel transcript discovery. Theoret-
ically, all splicing events as well as chimeric transcripts can be
directly detected [10]. However, the RNA-seq downstream data
analysis still remains a big challenge.
Several major alternative splicing forms, such as exon skipping,
mutually exclusive exon, alternative first/last exon and intron
retention, can be detected by simply mapping RNA-seq reads to
hypothetical splicing junctions. The reliability of a splicing
junction is determined by: 1) number of reads mapping to the
junction (junction reads); 2) number of mismatches on each
mapped read; 3) read mapping position on the junction, i.e. how
close is the center of the read to the junction itself. The shorter the
distance is, the less likely that this mapping is simply by chance; 4)
Mismatch position on junction read, e.g. mismatches occurring at
both ends of reads are more likely due to the sequencing error,
while those occurring in the middle of read are more likely to be
polymorphisms [11].
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quantitative information of junction reads, i.e. an exon junction
is considered to be real if it has more than R junction reads (R=1
or 2) [12,13]. This read-counting method, as demonstrated in the
results, has both high false positive and false negative rates. On the
other hand, in one of the two earliest pioneering human
transcriptome studies, Pan et al [3] used features similar to those
described above to train both linear and nonlinear classifiers for
true splicing junction detection, and achieved superior results.
In this paper, we introduced a new statistical metric, namely
Minimal Match on Either Side of Exon junction (MMES), as a
means to measure the ‘‘quality’’ of junction reads by integrating all
the features listed above. Then, we presented a simple yet effective
empirical statistical model using this metric to detect splicing
junctions with real RNA-seq data. When validated by two highly
reliable mouse transcript databases, this MMES based empirical
method is shown to be remarkably more accurate than read-
counting method, and also better than the logistic regression
method used in Pan et al [3].
Results
1) Overview of MMES
The MMES score for each junction read is calculated as:
MMES~Min Larm{Lmismatch ðÞ , Rarm{Rmismatch ðÞ ðÞ
where Larm and Rarm correspond to the left and right portions of the
read split by joint point of exon junction, respectively. While
Lmismatch and Rmismatch are number of mismatches occurred on Larm
and Rarm, respectively (Figure 1A).
For each junction read, the MMES score captured the criteria
2–4 listed above in an integrative manner. First, a junction read
with fewer mismatches will have a higher MMES score. Second, a
junction read with its center closer to the junction itself will have a
higher MMES score. Finally, MMES can give a rough estimate of
the positions of mismatches: When a read was divided into ‘‘long
arm’’ and ‘‘short arm’’ by the middle point of exon junction, in
most cases, mismatches on ‘‘long arm’’ have no effect on MMES
score, while mismatches on ‘‘short arm’’ will reduce the MMES
score. In summary, MMES is an integrated metric for measuring
mapping quality, indicating the combinatorial effect of the position
of the read relative to the junction and the position of the
mismatch(es) in the alignment.
2) Non-Uniform Distribution of MMES Scores
We mapped a real RNA-seq dataset (.200M 25 bp reads) from
mouse brain, liver and muscle [13] to both Exon Spliced Junction
(ESJ, see Methods) and, as a negative control, Exon Random
Junction (ERJ, see Methods) databases using SOAP (v1.11) with
up to 2 mismatches allowed [14]. Although easy to calculate and
informative, MMES is somewhat less powerful to discern different
number of mismatches (i.e. 1-mismatch vs 2-mismatch). For
example, additional mismatch on ‘‘long arm’’ has no effect on
MMES score. Therefore, we divided all junction reads into 3
categories (0-mismatch, 1-mismatch and 2-mismatch), and then
calculated MMES score distribution for each category, respec-
tively. (Figure 1B). Grouping junction reads according to
mismatches is necessary, because number of mismatches have
great impact on mapping specificity, especially for shorter reads.
This classification was also performed in previous ChIP-seq study
[15].
In general, there were much more reads aligned to ESJ than to
ERJ. Reads aligned to ESJ were almost uniformly distributed
regardless of MMES score. In contrast, reads mapped to negative
control ERJ presented a skewed distribution, i.e. the number of
mapped reads drops dramatically with the increase of MMES
score, which indicated that there were only a few reads having
their centers close to exon junctions. Furthermore, for exact match
(0-mismatch), several orders of magnitude more reads map to ESJ
than to ERJ regardless of the MMES scores, which implied that
exact match reads were the most reliable to detect spicing
junction, no matter which part of the junction the read was aligned
to. However, if there were mismatches especially 2-mismatches,
nearly the same number of reads (with small MMES scores) will
map to ESJ as well as ERJ (Table S1). This strongly indicated that
the reliability of 2-mismatch read alignment largely depended on
the corresponding MMES score, i.e. those with large MMES score
Figure 1. MMES metric and its skewed distribution over ESJ
and ERJ. (A) Calculation of Minimal Match on Either Side (MMES) of
junction. Each square represents a nucleotide. The figure shows that
eight 25-mer reads are aligned to a 42-mer exon junction (the bottom).
The exon junction is composed of two equal parts: the left part (filled in
red) is from the last 21bp of the upstream exon, and the right part (filled
in blue) is from the first 21 bp of the downstream exon. Within aligned
reads, the matched nucleotides are colored in either red (left) or blue
(right), and the mismatch nucleotides are blank. MMES score is placed
on the right side of each read. (B) MMES score (see main text)
distribution on Exon Splicing Junction (ESJ, red lines) and Exon Random
Junction (ERJ, blue lines). For both ESJ and ERJ, mapped reads are
divided into 3 categories: 0 mismatch (circle), 1 mismatch (triangle) and
2 mismatches (cross).
doi:10.1371/journal.pone.0008529.g001
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score were non-specific mapping artifacts. The latter cannot be
applied to identify splicing junctions without further calibration.
We also performed the same analysis on another RNA-seq
dataset from human embryonic kidney and B cell line [12], and
obtained very similar results (Figure S1, Table S1). We further
demonstrated that this non-uniform distribution of MMES is not
due to the uniqueness of read mapping, as similar distributions
were observed in both uniquely and non-uniquely matched
junction reads, for both human and mouse datasets (Figure S2).
3) Error Rate for Exon Junction Detection
The error rate of a read mapping to an exon junction (Pread) can
be empirically estimated from RNA-seq reads themselves, based
on the MMES score distributions on ESJ (as observation) versus
ERJ (as negative control).
Pread N,M ðÞ ~
# hits on ERJ fg
# hits on ESJ fg
where N is MMES score and M is number of mismatches
(M[½0,1,2  if maximum 2 mismatches allowed). Finally, the
‘pseudo’ p-value (thereafter p-value) of the exon junction (Pjunction)
was calculated as the product of mapping error rates from all
junction reads. A p-value threshold was subsequently selected
(based on FDR) to call all the true exon junctions.
Pjunction~PPread N,M ðÞ
In conclusion, this empirical p-value is a measurement of
reliability of junction. It was calculated based on collective effect of
mapped reads, and different read had different weight according
to its ‘‘mapping quality’’. The smaller p-value indicates the better
reliability.
4) Comparison with Read-Counting Method
One drawback of read-counting method was that it failed to
consider the detailed information of alignment such as mapping
position and number of mismatches, and therefore, assigned all
mapped reads the same weight. Another major problem was that it
was difficult to set a reasonable threshold R, as the minimum
number of covering reads with which a splicing junction would
be accepted. Because as shown in Figure 2A, almost every R
threshold in read-counting method presented a wide dynamic
range of p-value inferred from our statistical method. For example,
45% of 2-read-covering junctions (R=2) were rejected by our
statistical method (p-value.0.01), while 55% was accepted
(p-value#0.01). From Figure 2B, we can see that on average
46% (this is the under-estimated percentage, see Discussion) of
junctions with p-value#0.01 can be verified by transcripts
database, while only less than 5% of junction with p-value.0.01
can be verified.
Here we used 0.01 as a p-value cutoff, since the corresponding
false discovery rate (FDR) is less than 5% (Figure 2A). The FDR
was estimated by applying the same criteria to our negative control
database (ERJ).
To further confirm that our empirical method performed better
than read-counting method, we divided all splicing junctions
predicted either by read-counting or our MMES based method
into 3 non-overlapping categories: MMES model uniquely
predicted (‘‘P0.01_uniq’’, p-value#0.01, R=1), read-counting
method uniquely (‘‘R2_uniq’’, p-value.0.01, R$2), and predicted
by both methods (‘‘Common’’, p-value#0.01, R$2) (Figure 3A).
For each group, we then checked the validation rate (i.e. positive
predictive value; PPV, see discussion), using highly reliable
Figure 2. Performance of MMES based empirical method. (A)
Relationship between ‘‘percent of splicing junctions detected’’ and
p-value cut-off threshold. Splicing junctions are grouped by the number
of covering reads R, the pink line indicates the incurred FDR when the
corresponding cutting-off p-value is selected, and the vertical dashed
line indicates the p-value=0.01 cutoff (with incurred FDR=4.8%). (B) In
case of p-value threshold=0.01, all junctions are divided into two
classes: those junctions with p-value#0.01 are predicted to be real,
while those junctions with p-value.0.01 are predicted to be false. Each
class is further divided into 5 sub-classes according to number of
covering reads. For each sub-class, percent of junctions verified (PPV) is
calculated by cross validating predicted junctions with combined
alternative splicing database.
doi:10.1371/journal.pone.0008529.g002
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as positive control. The results indicated that 63.26% of the
‘‘Common’’ and 30.13% of ‘‘P0.01_uniq’’ splicing junctions could
be rediscovered in CASD, while only 4.86% of ‘‘R2_uniq’’ splicing
junctions were observed in CASD (Figure 3B). The PPV difference
between ‘‘R2_uniq’’ and ‘‘P0.01_uniq’’ was statistically significant
with Fisher’s Exact Test p-value=3.3610
254. To our surprise, the
low PPV (4.86%) of those R2 unique splicing junctions were almost
constant regardless of the number of junction reads (Figure 2B),
although PPV of the common splicing predictions rose dramati-
cally with the increase of the number of junction reads.
The read-counting method (with R=2 cutoff) had some
intrinsic problems especially in detecting splicing junctions in
low-abundance transcripts, where, in most cases, only one read
was mapped to a splicing junction. For example, in mouse brain
tissue, 20,945 non-consecutive exon junctions (skipped junctions)
were supported by RNA-seq reads, of which 86.34% (18,088/
20,945) were covered only by one read (Figure S3). Not
surprisingly, many of them are real exon junctions rather than
false positives, because as shown in Figure 3B, 30.13% of them can
be found in CASD. And we believe 30.13% was an under-
estimated number as low abundance transcripts were poorly
represented in CASD (see discussion).
Taking all together, we demonstrated that our MMES-based
empirical statistical approach is more accurate than previous used
read-counting method. In terms of method-specific predictions (i.e.
junctions predicted only by one method rather than the other), our
method is roughly 66more accurate than read-counting method.
5) Comparison with Logistic Regression Model
Logistic regression (logit model) allows one to predict a binary
outcome from a set of predictor variables, which could be continues
ordiscrete ormixofanyofthese.Webuiltalogisticregressionmodel
using the same features in Pan et al. (see Methods). Basically, these
features incorporate all the quantity and quality information of
mapped reads, and all have strong p-values for the associated
regression coefficients. When performing a log-likelihood test
(comparing this logit model with empty model which only had an
intercept), we received a p-value=0 (x
2=106751, df=6), indicating
this logit model as a whole fits significantly better than empty model.
Figure 3. Comparison of MMES based empirical approach with read-counting method and logistic regression model. (A) All splicing
junctions predicted by either method are divided into 3 non-overlapping categories: ‘‘P0.01_uniq’’ refers to those junctions with only 1 covering read
but with p-value#0.01 (green); ‘‘R2_uniq’’ refers to junctions with at least 2 covering reads but with p-value.0.01 (red). ‘‘Common’’ refers to those
junctions with at least 2 covering reads and with p-value#0.01 (blue). (B) Validation rate (PPV) for ‘‘P0.01_uniq’’, ‘‘R2_uniq’’, and ‘‘Common’’,
respectively. (C) ‘‘P0.01_uniq’’ refers to those junctions detected by MMES based empirical method only (green), ‘‘LR_uniq’’ refers to those junctions
identified by logistic regression only (red), ‘‘BothSig’’ refers to junctions identified by both models (blue) and ‘‘BothUnsig’’ refers to junctions rejected
by both method. (D) Validation rate (PPV) for ‘‘P0.01_uniq’’, ‘‘LR_uniq’’, and ‘‘Common’’, respectively.
doi:10.1371/journal.pone.0008529.g003
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logistic regression model the same way as before: all predicted
junction by MMES based method (designated as P0.01) and
logistic regression model (designated as LR) were divided into 3
non-overlapping categories: common, P0.01_uniq and LR_uniq
(Figure 3C). For commonly predicted junctions, 48.78% can be
verified by CASD, while for P0.01_uniq and LR_uniq junctions,
18.40% and 13.75% can be verified, respectively (Figure 3D). In
terms of uniquely predicted junctions, MMES model is 1.3 times
more accurate than LR model (p-value=1.7610
23). Further-
more, by using 10-fold cross-validation, we obtained highly
significant and comparable AUC scores from both logistic
regression model (AUC=0.981) and our empirical method
(AUC=0.982). Finally, we added the MMES feature to this logit
model to see whether MMES score is also superior when used in
Pan et al’s approach. The results indicated that the model was
indeed improved, measured by both AUC and validation rate, but
still not as good as our empirical approach (Figure S4).
6) Experimental Validation of False Positive and False
Negative
We randomly selected 20 false positive (FP) and several false
negative (FN) splicing junctions for experimental validation by
RT-PCR followed by Sanger sequencing (Table S2). False positive
splicing junctions refer to those covered by at least 2 reads but with
p-value.0.01 in our statistical method. False negative splicing
junctions refer to those covered by 1 read but with p-value#0.01.
We chose splicing junctions with relatively higher RNA-seq read
coverage for RT-PCR analysis. Of the 20 FPs tested, all were
confirmed, yielding a validation rate of 100%. An example was
shown in Figure S5. In contrast, false negative is difficult to verify
with RT-PCR/Sanger sequencing because those transcripts
usually have extremely low expression level. As an alternative,
we analyzed the EST data in public domain and found that at least
30% of the false negatives were confirmed (see discussion). Two
examples were shown in Figure S6.
Discussion
1) Sensitivity, Specificity and Positive Predictive Value
(PPV)
Sensitivity, specificity and positive predictive value (PPV) are all
widely used statistical measures of the performance of a prediction
system. By definition, sensitivity refers to the proportion of actual
positives which are correctly predicted as positive; specificity is the
proportion of actual negatives which are correctly predicted as
negative; while PPV is the proportion of predicted positives which
are actual positive.
sensitivity~
TP
TPzFN
;specificity~
TN
TNzFP
;PPV~
TP
TPzFP
Where true positive (TP) refers to real exon junctions (i.e. exist in
vivo)whicharecorrectlyidentifiedasreal;falsepositive(FP)refersto
false exon junctions (i.e. not exist in vivo) which are incorrectly
identified as real; true negative (TN) refers to false exon junctions
which are correctly identified as false; and false negative (FN) refers
to real exon junctions which are incorrectly identified as false.
Here, sensitivity and specificity cannot be applied to evaluate
different methods for exon junction prediction, because we don’t
know the number of actual positive (TP+NF), i.e. the denominator
of sensitivity, or actual negative (TN+FP), i.e. the denominator
of specificity, in a specific tissue under a specific condition.
Furthermore, some low-abundance exon junctions may not be
detected just because the sequencing coverage is not deep enough,
not because of the prediction method used. On the other hand,
PPV can be determined as a statistical measure to compare our
method with other method since the number of true positives (TP),
i.e. the numerator of PPV, is confirmed by CASD, while the
number of predicted positives (TP+FP), i.e. the denominator of
PPV, is the result from each prediction method.
As shown in Figure 3B, 30% of the predicated splicing junctions
covered by 1 read (low abundance transcripts) were confirmed by
CASD. However, this does not imply that our model is less
powerful in detecting low abundance transcripts. First, the PPV for
low- abundance transcripts could be significantly under-estimated
since CASD is based on traditional assays such as EST sequencing,
which is much less sensitive than RNA-seq in detecting low
abundance transcripts. Based on current data, it is difficult to
evaluate the extent to which PPV is under estimated. Second, and
more importantly, unlike sensitivity and specificity, which will not
be affected by the ratio of positives to negatives in the sample, PPV
suffers greatly from this ratio, and because of this, the PPV value
per se cannot reflect the detecting power of a method [16].
2) Influence Factors for the Mapping Specificity of
Junction Reads
As shown in Figure S2 and Table S1, non-specific mapping to
exon junctions is a big problem for RNA-seq. In mouse dataset,
4,102,511 reads were mapped to ESJ, while 929,756 reads were
mapped to negative control ERJ. Therefore as high as 23%
(929,756/4,102,511) of those junction mappings are false positives.
In this paper, we showed that Minimal Match on Either Side of
exon junction (MMES) and the number of mismatches have very
strong impacts on mapping specificity. To further determine the
effect of other factors, such as read length, we performed the
following simulation: assuming a uniform i.i.d. random model for
DNA sequences, the number of random hits per junction per
million reads (X) can be determined by a Random Model reported
in Sultan et al. [12]. The results suggested that read length (RL) also
has a big impact on mapping specificity (Table S3). For example, if
two mismatches are allowed, X is 6.18610
29 when RL=32, which
is about four orders of magnitude lower than that (4.44610
25)
when RL=25. In general, other than increasing MMES and
reducing the allowable mismatches, one can also increase the
length of RNA-seq read to improve the mapping specificity.
3) Negative Control Databases
The mapping specificity of junction reads largely depends on
the negative control database. Pure random sequence (PRS)
shuffles the transcriptome in nucleotide level and therefore is
definitely not a good control as it failed to consider inherent
codon, dinucleotide and other compositional features. In contrast,
ERJ and rESJ shuffle the transcriptome in exon level (i.e. the basic
unit of shuffling is exon rather than nucleotide), and therefore
these two databases could inherently retain most of the
compositional features. As shown in Figure S7, both ERJ and
rESJ reserve the compositional features of ESJ in terms of single
nucleotide distribution. For example, the 5-mer motif near
junction site in ESJ, i.e. 59-[A|C]23A22G21G1T2 -39, can be
found in both ERJ and rESJ. ERJ and rESJ can also preserve the
compositional features in dinucleotide level (Table S4).
As expected, ERJ and rESJ almost give the same results when
serving as negative control. In terms of mapped reads, the Pearson’s
correlation coefficient between ERJ and rESJ is 0.987 (p=3.60610
214),
0.986 (p=5.75610
214) and 0.992 (p=8.88610
214) for exact
mapping, 1 mismatch mapping and 2 mismatch mapping,
respectively (Figure S8).
Detect Exon Junctions
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because they keep compositional features inherently, however,
ERJ is slightly more conservative in discriminating real splicing
junctions when there are mismatches (Figure S8).
4) Conclusions
MMES is an integrated metric for measuring mapping quality,
indicating the combinatorial effect of the position of the read
relative to the junction and the position of the mismatch(es) in the
alignment. Our MMES-based empirical statistical model is an
annotation-based method, which relies on junction databases
according to certain known gene model, and as shown in results,
outperformed previous methods in terms of method-specific
junction predictions. We believe that our MMES model provided
a timely contribution to the splicing detection using RNA-seq.
Materials and Methods
1) RNA-Seq Datasets
Two RNA-seq datasets from mouse and human were used in
this study. Mouse dataset consists of 215 million, 25-bp reads from
brain, liver and muscle. We downloaded the data from http://
woldlab.caltech.edu/,alim/RNAseq/ [13]. Human dataset con-
tains 13 million, 27-bp RNA-seqs from embryonic kidney and B
cell line. We downloaded these data from NCBI Gene Expression
Ominibus (www.ncbi.nlm.nih.gov/geo) with Accession Number
GSE11892 [12].
2) Exon Junction Sequences
We prepared several databases in this study—ESJ (Exon Spiced
Junction), ERJ (Exon Random Junction), rESJ (reversed Exon
spliced Junction). We used ESJ database to detect all the potential
exon skipping events. The ERJ and rESJ databases were used as
negative control with the merits of maintaining inherent codon,
dinucleotide and other possible compositional biases when
discriminating between true and false junctions. As negative
controls, ERJ and rESJ almost came up with the same results, so
we only used ERJ in this study (see discussion).
ESJ database was prepared by pairwise connection of exon
sequences from every locus annotated by UCSC knownGene
model (mm9, July, 2007). The last 21 bp of the upstream
exon was connected to the first 21 bp of the corresponding
downstream exon. We tried all possible combinations, e.g. exon
i was connected to exon i+1, exon i+2, etc. The 21-bp was
chose to ensure at least 4 nucleotides overlapping between one
of the two connected exons and a RNA-seq read. In our
simulation, using a criterion with less than 4 nucleotides
overlapping will introduce extraordinary non-specific RNA-seq
read mapping to exon junctions (data not shown). After
discarding those junctions shorter than reads and removing
redundancy, we built the ESJ database containing 1,976,416
possible junctions.
ERJ database was constructed exactly the same way as we
described for ESJ, except that two exons joined together were
randomly picked from 2 different loci. For our own convenience,
the sizes (i.e. total number of exon junctions) of 2 databases were
set to be the same. rESJ database was also built exactly the same
way as we built ESJ, except that we swapped the position of
upstream exon and downstream exon.
For the human dataset, we built ESJ and ERJ databases with
exactly the same method as we applied to mouse, based on UCSC
knownGene model (hg18, Mar. 2006). We had in total 2,782,935
exon junctions for ESJ, ERJ. The read length is 27 bp in this
dataset, so we connected the last 23 bp of upstream exon to the
first 23 bp of the corresponding downstream exon, to make sure
there is at least 4 bp overlapping between an exon and a RNA-seq
read.
3) Known Splicing Junction Databases
We used two high quality transcript databases to evaluate the
predicted junctions. These include the EBI Alternative Splicing
and Transcripts Diversity database (ASTD, v1.1) (http://www.ebi.
ac.uk/astd/main.html) and Mouse Gene Index database (v4.0)
developed by National Institute of Aging (http://lgsun.grc.nia.nih.
gov/geneindex4/index.html) [17,18]. All mouse transcripts se-
quences were downloaded and combined as a Combined
Alternative Splicing Database (CASD). All predicted exon
junctions were mapped to CASD with up to two mismatches
allowed. Percentage of junctions verified was measured by Positive
Predictive Value (PPV, see discussion), which is defined as:
PPV~
TP
TPzFP
.
4) Logistic Regression Model
We used exact the same features in Pan et al [3] in their
pioneering study of human transcriptome, except insertions/
deletions, because none of our short 25mer reads was aligned with
gaps when mapped to junctionome. Another logit model was build
by adding maximum MMES score to the above features. The
classifiers were trained on rESJ database (as negative) and
consecutive junctions (as positive) to obtain parameters. An R
package glm was use to implement this logistic regression and ROC
curve was plot using ROCR package [19].
5) Experimental Validation of False Positive and False
Negative
To experimentally validate the false positive and false negative
splice junctions, we designed exon-specific primers and carried out
Reverse Transcription Polymerase Chain Reaction (RT-PCR)o n
mouse skeletal muscle PolyA
+ RNA. The reaction for synthesizing
the 1
st strand cDNA consists of 2.0 mL of AccuScript RT buffer,
100 mM dNTP mix (25 mM each), 0.1mg mouse skeletal muscle
polyA RNA, 100 ng of reverse exon-specific primer in a final
volume of 16.5 mL. To denature the mRNA, the reactions were
first incubated at 65uC for 5 min, followed by 25uC for 5 min. We
then added 2.0 mL of 100 mM DTT, 1.0 mL AccuScript Reverse
Transcriptase, and 2.0 Units of RNase Block ribonuclease
inhibitor in that order. The reactions were incubated at 42uC
for an hour, and terminated by heat inactivation at 75uC for
15 min.
To amplify the second strand cDNA, 2 mL of reverse
transcription reaction product was transferred into a 50 mL PCR
mixture consisting of 5 mL1 0 6 PfuUltra PCR Buffer, 2.0 mL
25 mM magnesium chloride, 0.4 mL dNTP’s 25 mM each,
100 ng of forward and reverse primers and 0.1 mLo fPfuUltra
Taq 2.5 U/mL. PCR cycling began with template denaturation
and hot start Taq activation at 95uC for 1 min, followed by 40
cycles of 95uC for 30 sec, 55uC for 30 sec and 68uC for 3 min
each, and then termianted by an extension step at 68uC for
10 min. The PCR products were analyzed on 1.5% agarose gels,
and cloned into the pGEM-T TA cloning vector for sequencing.
The obtained sequences were then mapped to mouse genome
using UCSC genome browser for splice junction analyses. Mouse
skeletal muscle PolyA
+ RNA, PfuUltra II fusion HS DNA
Polymerase and AccuScript High Fidelity 1
st-Strand cDNA
Synthesis Kit were purchased from Stratagene, and pGEM-T
TA cloning vector from Promega.
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Figure S1 MMES distribution for Human RNA-seq. Compar-
ison of MMES distribution between Exon Splicing Junction (ESJ,
red lines) and Exon Randomly Junction (ERJ, blue lines) for
Human RNA-seq dataset. Mapped reads are divided into 3
categories: 0 mismatch (triangle), 1 mismatch (cross) and 2
mismatches (diamond).
Found at: doi:10.1371/journal.pone.0008529.s001 (0.02 MB
PDF)
Figure S2 Comparison of MMES for uniquely mapped reads
(square) and non-uniquely mapped reads (triangle). (A) Mouse
dataset, (B)Human dataset.
Found at: doi:10.1371/journal.pone.0008529.s002 (0.29 MB
PDF)
Figure S3 Pie chart of non-consecutive junctions. Nonconsec-
utive exon junctions (skipped junctions) are divided into 5 groups,
according to number of covering reads (R).
Found at: doi:10.1371/journal.pone.0008529.s003 (0.14 MB
PDF)
Figure S4 ROC curve of logistic regression model. (A), (B)
Receiver Operating Characteristic (ROC) curves for logistic
regression model without and with MMES feature, respectively.
Blue dots indicate 10 cross-validation runs, red solid line is average
curve (C) Validation rates of commonly predicted junctions
(‘‘Common’’, blue), MMES-based empirical method (‘‘P0.01_uniq’’,
green), logistic regression model without MMES feature (‘‘LR
(MMES-) uniq’’, red)’’ and logistic regression model with MMES
feature (‘‘LR (MMES+) uniq’’, pink).
Found at: doi:10.1371/journal.pone.0008529.s004 (1.28 MB
PDF)
Figure S5 Examples of false positive. (A) A junction between
exon2 and exon4 (the first exon is indexed as 0) of Tnnc2
(uc008nvz.1) is covered by 6 reads but with p-value=1, and
therefore is rejected by MMES statistic model (cutoff p-
value=0.01). (B) Screen shot form UCSC genome browser. We
design exon specific primer pair (forward primer on exon2 and
reverse primer on exon 4) and carry out RT-PCR on mouse
muscle total RNA. 23 randomly picked clones from the PCR
product are sequenced, without observing the anticipated junction
(p,0.05).
Found at: doi:10.1371/journal.pone.0008529.s005 (0.70 MB
PDF)
Figure S6 Examples of false negative. (A) A junction between
exon1 and exon3 of gene Polr2d (uc008eim.1) is covered by 1 read
but with significant p-value=8.9610
25. (B) This junction is
confirmed by 3 independent EST sequences. (C) A junction
between exon1 and exon3 of gene Mcat (uc007xbf.1) is covered by
1 read but with significant p-value=6610
26. (D) This junction is
supported by 2 independent EST sequences. Skipped exon is
indicated with red arrow.
Found at: doi:10.1371/journal.pone.0008529.s006 (0.63 MB
PDF)
Figure S7 Single nucleotide frequency distribution of ESJ, ERJ
and rESJ. Coordinates (59 to 39) of oligo from last 21bp of
upstream exon are indexed from 221 to 21, and coordinates (59
to 39) of oligo from first 21bp of downstream exon are indexed
from 1 to 21.
Found at: doi:10.1371/journal.pone.0008529.s007 (0.75 MB
PDF)
Figure S8 Compare mapped reads distribution among ESJ, ERJ
and rESJ. For each database, mapped reads were divided into 3
categories: 0-mismatch (exact match), 1-mismatch and 2-mis-
match. The mapping position of each mapped read was
represented by its middle-point. (A) ESJ vs ERJ, (B) ESJ vs rESJ,
(C) ERJ vs rESJ.
Found at: doi:10.1371/journal.pone.0008529.s008 (0.82 MB
PDF)
Table S1 Distribution of mapped reads over exon junctions.
Each read is represented by its midpoint. (A) Mouse dataset. (B)
Human dataset.
Found at: doi:10.1371/journal.pone.0008529.s009 (0.02 MB
PDF)
Table S2 List of selected false positive exon junctions and
primers.
Found at: doi:10.1371/journal.pone.0008529.s010 (0.03 MB
PDF)
Table S3 Simulation of false positive hits based on random
model. Read length varies from 10 to 50. Number of mismatch
ranges from 0 to 5.
Found at: doi:10.1371/journal.pone.0008529.s011 (0.02 MB
PDF)
Table S4 Distribution of dinucleotide frequency across ESJ,
rESJ and ERJ.
Found at: doi:10.1371/journal.pone.0008529.s012 (0.07 MB
PDF)
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